A simple score for assessing stable chronic obstructive pulmonary disease

被引:41
作者
Esteban, C.
Quintana, J. M.
Aburto, M.
Moraza, J.
Capelastegui, A.
机构
[1] Hosp Galsakai, Serv Pneumol, Galdakao 48960, Bizkaia, Spain
[2] Hosp Galsakai, Res Unit, Galdakao 48960, Bizkaia, Spain
关键词
D O I
10.1093/qjmed/hcl110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic obstructive pulmonary disease (COPD) is usually assessed using FEV1 to establish the diagnosis and the severity of the disease. However, COPD is now considered a systemic disease. To evaluate the utility of the Health-Activity-Dyspnoea-Obstruction (HADO) score for classifying the severity of COPD and predicting outcomes. Design: Prospective longitudinal clinical study. Methods: We studied 611 consecutive patients with stable COPD in five out-patient clinics of a teaching hospital. We measured dyspnoea degree, pulmonary function (by spirometry), self-reported level of daily physical activity and overall health condition. Outcome measures included health-related quality of life (HRQoL) parameters (as measured by the generic SF-36 Health Survey and by two specific questionnaires, the St George Respiratory Questionnaire and the Chronic Respiratory Questionnaire) and mortality at 3 years follow-up. Results: Based on the HADO score, COPD was classified as mild in 26.7% of patients, moderate in 53.3%, and severe in 20%. There were statistically significant correlations between these three levels of severity and HRQoL parameters and vital status. After adjustment for relevant covariates, the HADO score reliably predicted survival and vital status. Discussion: The HADO score can be easily obtained in an out-patient clinic, and distinguishes groups of COPD patients by their disease severity. The HADO score is better than FEV1% alone for predicting mortality at 3 years.
引用
收藏
页码:751 / 759
页数:9
相关论文
共 44 条
[1]   Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease [J].
Alonso, J ;
Prieto, L ;
Ferrer, M ;
Vilagut, G ;
Broquetas, JM ;
Roca, J ;
Batlle, JS ;
Antó, JM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1087-1094
[2]   Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective [J].
Andreassen, H ;
Vestbo, J .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 :2S-4S
[3]  
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107
[4]   PROGNOSIS IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
WRIGHT, EC ;
HODGKIN, JE ;
HOPEWELL, PC ;
LEVIN, DC ;
STEVENS, PM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (01) :14-20
[5]   Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[6]   Functional status and survival following pulmonary rehabilitation [J].
Bowen, JB ;
Votto, JJ ;
Thrall, RS ;
Haggerty, MC ;
Stockdale-Woolley, R ;
Bandyopadhyay, T ;
ZuWallack, RL .
CHEST, 2000, 118 (03) :697-703
[7]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[8]  
CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77
[9]   Muscle weakness is related to utilization of health care resources in COPD patients [J].
Decramer, M ;
Gosselink, R ;
Troosters, T ;
Verschueren, M ;
Evers, G .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (02) :417-423
[10]   Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease [J].
Domingo-Salvany, A ;
Lamarca, R ;
Ferrer, M ;
Garcia-Aymerich, J ;
Alonso, J ;
Félez, M ;
Khalaf, A ;
Marrades, RM ;
Monsó, E ;
Serra-Batlles, L ;
Antó, JM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (05) :680-685